NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Rosen Law Firm, a
global investor rights law firm, announces it is investigating
potential securities claims on behalf of shareholders of Teva
Pharmaceutical Industries Ltd. (NYSE: TEVA) resulting from
allegations that Teva may have issued materially misleading
business information to the investing public.
According to news reports, United
States prosecutors may file criminal charges against Teva by
the end of 2016 for suspected price collusion.
On November 3,
2016, Bloomberg reported that the "antitrust
investigation by the Justice Department, begun about two years ago,
now spans more than a dozen companies and about two dozen drugs,
according to people familiar with the matter. The grand jury
probe is examining whether some executives agreed with one another
to raise prices, and the first charges could emerge by the end of
the year, they said." On this news, Teva fell sharply, damaging
investors.
Rosen Law Firm is preparing a class action lawsuit to recover
losses suffered by Teva investors. If you purchased shares of Teva
please visit the firm's website at
http://www.rosenlegal.com/cases-979.html for more information. You
may also contact Phillip Kim or
Kevin Chan of Rosen Law Firm toll
free at 866-767-3653 or via email at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a
similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Logo - http://photos.prnewswire.com/prnh/20160907/405060LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/equity-alert-rosen-law-firm-announces-investigation-of-securities-claims-against-teva-pharmaceutical-industries-ltd---teva-300357701.html
SOURCE Rosen Law Firm, P.A.